ALLERGAN INC·4

Jan 6, 7:12 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Jan 6, 2015

Insider Transaction Report

Form 4
Period: 2015-01-02
Transactions
  • Award

    Phantom Stock Units

    2014-12-11$211.14/sh+0.88$1867,431.83 total
    Common Stock (0.88 underlying)
  • Award

    Phantom Stock Units

    2015-01-02$212.75/sh+70.5$14,9997,502.33 total
    Common Stock (70.5 underlying)
Footnotes (4)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program for quarterly dividend, exempt transaction under Rule 16a-11.
  • [F3]Phantom stock units are to be settled 100% in common stock upon the Reporting Person's retirement as an Allergan, Inc. director.
  • [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program for quarterly portion of annual retainer.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT